Ashutosh Barve

1.2k total citations
26 papers, 910 citations indexed

About

Ashutosh Barve is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Ashutosh Barve has authored 26 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Hepatology and 7 papers in Epidemiology. Recurrent topics in Ashutosh Barve's work include Liver Disease Diagnosis and Treatment (7 papers), RNA Interference and Gene Delivery (7 papers) and Liver Disease and Transplantation (6 papers). Ashutosh Barve is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), RNA Interference and Gene Delivery (7 papers) and Liver Disease and Transplantation (6 papers). Ashutosh Barve collaborates with scholars based in United States and India. Ashutosh Barve's co-authors include Kun Cheng, Wei Jin, Craig J. McClain, Akshay Jain, Zhen Zhao, Matthew C. Cave, Mohammad K. Mohammad, Luis Marsano, Yuanke Li and Shirish Barve and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Ashutosh Barve

23 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashutosh Barve United States 15 295 200 198 151 147 26 910
Leonard Kaps Germany 19 318 1.1× 229 1.1× 152 0.8× 99 0.7× 234 1.6× 66 1.2k
Juan Cheng China 19 342 1.2× 166 0.8× 104 0.5× 170 1.1× 135 0.9× 48 1.3k
Leyuan Xu United States 26 615 2.1× 134 0.7× 181 0.9× 159 1.1× 156 1.1× 36 1.4k
Weiping Zhu China 19 435 1.5× 76 0.4× 77 0.4× 66 0.4× 160 1.1× 53 916
Changhua Zhang China 25 660 2.2× 192 1.0× 106 0.5× 160 1.1× 521 3.5× 95 1.7k
Qianqian Yu China 13 299 1.0× 40 0.2× 69 0.3× 168 1.1× 319 2.2× 45 1.1k
Zhongtian Bai China 16 439 1.5× 85 0.4× 62 0.3× 93 0.6× 133 0.9× 52 911
Maria Principia Scavo Italy 19 394 1.3× 136 0.7× 66 0.3× 70 0.5× 89 0.6× 57 877
Qianqian Yu China 21 552 1.9× 49 0.2× 133 0.7× 184 1.2× 218 1.5× 37 1.0k

Countries citing papers authored by Ashutosh Barve

Since Specialization
Citations

This map shows the geographic impact of Ashutosh Barve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashutosh Barve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashutosh Barve more than expected).

Fields of papers citing papers by Ashutosh Barve

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashutosh Barve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashutosh Barve. The network helps show where Ashutosh Barve may publish in the future.

Co-authorship network of co-authors of Ashutosh Barve

This figure shows the co-authorship network connecting the top 25 collaborators of Ashutosh Barve. A scholar is included among the top collaborators of Ashutosh Barve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashutosh Barve. Ashutosh Barve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Sheel, et al.. (2025). HCC in MASLD and ALD: Biochemical Pathways, Epidemiology, Diagnosis, and Treatment. SHILAP Revista de lepidopterología. 5(3). 19–19.
2.
Vohra, Ishaan, et al.. (2022). An Unusual Case of Hemolytic Anemia Reversed with Liver Transplantation. International Journal of Hematology-Oncology and Stem Cell Research. 16(2). 128–130.
3.
Liu, Hao, Yanli Liu, Zhen Zhao, et al.. (2022). Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy. Frontiers in Immunology. 13. 838966–838966. 10 indexed citations
4.
Barve, Ashutosh, et al.. (2022). Drug Use Evaluation of Direct Oral Anticoagulants (DOACs) in Patients With Advanced Cirrhosis. Cureus. 14(4). e24029–e24029. 5 indexed citations
5.
Ranganathan, Parthasarathy, Maiying Kong, Melanie L. Schwandt, et al.. (2022). Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis. International Journal of Molecular Sciences. 23(10). 5852–5852. 4 indexed citations
6.
Barve, Ashutosh, et al.. (2021). S3399 Evaluation of the Use of Direct Oral Anticoagulants in Patients With Cirrhosis. The American Journal of Gastroenterology. 116(1). S1398–S1398. 1 indexed citations
7.
Barve, Ashutosh, Akshay Jain, Hao Liu, Zhen Zhao, & Kun Cheng. (2020). Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy. Acta Biomaterialia. 113. 501–511. 92 indexed citations
8.
Zhao, Zhen, Yuanke Li, Ravi Shukla, et al.. (2019). Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer. Theranostics. 9(15). 4508–4524. 43 indexed citations
9.
Liu, Hao, Zhen Zhao, Li Zhang, et al.. (2019). Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 7(1). 270–270. 104 indexed citations
10.
Liu, Hao, Zhijin Chen, Wei Jin, et al.. (2017). Silencing of α-complex protein-2 reverses alcohol- and cytokine-induced fibrogenesis in hepatic stellate cells. Liver Research. 1(1). 70–79. 17 indexed citations
11.
Jin, Wei, Bin Qin, Zhijin Chen, et al.. (2016). Discovery of PSMA-specific peptide ligands for targeted drug delivery. International Journal of Pharmaceutics. 513(1-2). 138–147. 43 indexed citations
12.
Barve, Ashutosh, Akshay Jain, Hao Liu, Wei Jin, & Kun Cheng. (2016). An enzyme-responsive conjugate improves the delivery of a PI3K inhibitor to prostate cancer. Nanomedicine Nanotechnology Biology and Medicine. 12(8). 2373–2381. 28 indexed citations
13.
Jin, Wei, Ashutosh Barve, & Kun Cheng. (2016). PSMA-Specific Ligands in Prostate Cancer Diagnosis and Therapy. 62–69. 4 indexed citations
14.
Buchanan, Laura, Christina Pinkston, Ashutosh Barve, et al.. (2016). Simeprevir and sofosbuvir with or without ribavirin to treat recurrent genotype 1 hepatitis C virus infection after orthotopic liver transplantation. Liver Transplantation. 22(5). 635–643. 17 indexed citations
15.
Barve, Ashutosh, Wei Jin, & Kun Cheng. (2014). Prostate cancer relevant antigens and enzymes for targeted drug delivery. Journal of Controlled Release. 187. 118–132. 92 indexed citations
16.
Tai, Wanyi, Zhijin Chen, Ashutosh Barve, Zhonghua Peng, & Kun Cheng. (2013). A Novel Rapamycin-Polymer Conjugate Based on a New Poly(Ethylene Glycol) Multiblock Copolymer. Pharmaceutical Research. 31(3). 706–719. 24 indexed citations
17.
Mohammad, Mohammad K., et al.. (2012). Zinc and Liver Disease. Nutrition in Clinical Practice. 27(1). 8–20. 172 indexed citations
18.
McClain, Craig J., Shirish Barve, Ashutosh Barve, & Luis Marsano. (2011). Alcoholic Liver Disease and Malnutrition. Alcoholism Clinical and Experimental Research. 35(5). 815–820. 80 indexed citations
19.
Barve, Ashutosh, et al.. (2009). Drug-Induced Hepatotoxicity or Drug-Induced Liver Injury. Clinics in Liver Disease. 13(2). 277–294. 37 indexed citations
20.
Barve, Ashutosh, Rehan Khan, Luis Marsano, Kadiyala V. Ravindra, & Craig J. McClain. (2008). Treatment of alcoholic liver disease. Annals of Hepatology. 7(1). 5–15. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026